Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Lorazepam vs Intramuscular Paraldehyde for Childhood Convulsions
NCT00116064Phase 3Completed
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lorazepam in status epilepticus (SE) and epilepsy (2 arms). Primary endpoint: Seizure cessation within 10 minutes. Started Jul 2004; status: completed.
02
Drugs
lorazepam
03
Conditions
status epilepticus (SE)epilepsy
Beyond the preview
Go deeper on NCT00116064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116064.